This topic contains a solution. Click here to go to the answer

Author Question: Neuronal action potentials follow __________. a. temporal markers b. the all or none principle ... (Read 18 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
Neuronal action potentials follow __________.
 
  a. temporal markers
  b. the all or none principle
  c. in sequence
  d. an encoding stage

Question 2

The synapsing of a give neuron with many other neurons is called __________.
 
  a. multiplicity
  b. magnification
  c. divergence
  d. diffusion



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bigsis44

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

Answer: b

Answer to Question 2

Answer: c




captainjonesify

  • Member
  • Posts: 543
Reply 2 on: Jun 20, 2018
Gracias!


rachel

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library